Differential effects of sumoylation on the activities of CCAAT enhancer binding protein alpha (C/EBPα) p42 versus p30 may contribute in part, to aberrant C/EBPα activity in acute leukemias

Hematology Reports

Volumn 3, Issue 1, 2011, Pages 13-17

  Hankey, William ^a   Silver, Matthew ^b   Sun, Bshong ^b   Zibello, Terry ^b   Berliner, Nancy ^b   Khanna Gupta, Arati ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Leukemogenesis; Myeloid transcription; Post translational modification; Sumoylation

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; LACTOFERRIN; PROTEIN P30; PROTEIN P42; RETINOIC ACID;

ACUTE LEUKEMIA; ARTICLE; BONE MARROW CELL; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMOGENESIS; NEUTROPHIL; ONCOGENE; ONCOGENE LF; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SUMOYLATION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 80052040994     PISSN: 20388322     EISSN: 20388330     Source Type: Journal    
DOI: 10.4081/hr.2011.e5     Document Type: Article

References (17)

1. Khanna-Gupta A. Sumoylation and the function of CCAAT enhancer binding protein alpha (C/EBP alpha). Blood Cell Mol Dis 2008:41;77-81.
2. Pabst T, Muller B, Zhang P. Dominant negative mutations of CEBPA encoding CCAAT/enhancer binding protein-a (C/EBPa), in acute myeloid leukemia. Nat Genet 2001;27:263-270.
3. Muller B, Pabst T. C/EBPa and the pathophysiology of acute myeloid leukemia. Curr Opin Hematol 2006;13:7-14.
4. Koschmieder S, Halmos B, Levantini E, Tenen DG. Dysregulation of the C/EBPalpha differentiation pathway in human cancer. J Clin Oncol 2009:27;619-628.
5. P. Kirstetter, Schuster MB, Bereshchenko O, et al. Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell 2008;13:299-310.
6. Khanna-Gupta A, Zibello T, Sun H, et al. Chromatin immunoprecipitation (ChIP) studies indicate a role for CCAAT enhamcer binding proteins alpha and epsilon (C/EBPa and C/EBPε) and CDP/cut in myeloid maturation induced lactoferrin gene expression. Blood 2003;101:3460-3468.
7. Sato Y.K, Miyake H, Kaneoka H, Iijima S. Sumoylation of CCAAT/enhancer binding protein a and its functional roles in hepatocyte differentiation. J Biol Chem 2006;281:21629-21639.
8. Geletu M, Balkhi M, Peer Zada A, et al. Behre, Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9. Blood 2007;110:3301-3309.
9. Khanna-Gupta A, Kolibaba K, Zibello TA, Berliner N. NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. Blood 1994;84:294-302.
10. Lawson ND, Krause DS, Berliner N. Normal neutrophil differentiation and secondary granule gene expression in the EML and MPRO cell lines. Exp Hematol 1998;26:1178-1185.
11. Khanna-Gupta A, Zibello TA, Simkevich C, et al. Sp1 and C/EBP are necessary to activate the lactoferrin gene promoter during myeloid differentiation. Blood 2000;95:3734-3741.
12. Khanna-Gupta A, Zibello T, Kolla S, et al. CCAAT displacement protein (CDP/cut) recognizes a silencer element within the lactoferrin gene promoter. Blood 1997;90:2784-2795.
13. Khanna-Gupta A, Zibello T, Idone V, et al. Human neutrophil collagenase expression is C/EBP-dependent during myeloid development. Exp Hematol 2005;33:42-52.
14. Subramanian L, Benson M, Iniguez-Lluhi J. A synegy control motif within the attenuator domain of CCAAT/enhancer binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or Sumo-3. J Biol Chem 2003;278:9134-9141.
15. Fu CT, Zhu KY, Mi JQ, et al. An evolutionarily conserved PTEN-C/EBPα-CTNNA1 axis controls myeloid development and transformation. Blood 2010;115:4715-4724.
16. Gombart A, Hofmann W, Kawano S, et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood 2002;99:1332-1340.
17. Green C, Koo KK, Hills RK, et al. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. J Clin Oncol 2010;28:2739-2747.